{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:24:14Z","timestamp":1790742254508,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":41,"publisher":"Springer New York","isbn-type":[{"value":"9781493977765","type":"print"},{"value":"9781493977789","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7778-9_14","type":"book-chapter","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T02:32:45Z","timestamp":1525141965000},"page":"229-256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders"],"prefix":"10.1007","author":[{"given":"Daniela","family":"Drandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ladetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1200\/JCO.2008.21.3116","volume":"27","author":"NS Andersen","year":"2009","unstructured":"Andersen NS, Pedersen LB, Laurell A et al (2009) Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma. J Clin Oncol 27:4365\u20134370","journal-title":"J Clin Oncol"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1200\/JCO.2009.23.7172","volume":"28","author":"M Ladetto","year":"2010","unstructured":"Ladetto M, Pagliano G, Ferrero S et al (2010) Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma. J Clin Oncol 28:2077\u20132084","journal-title":"J Clin Oncol"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","volume":"115","author":"C Pott","year":"2010","unstructured":"Pott C, Hoster E, Delfau-Larue MH et al (2010) Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. Blood 115:3215\u20133223","journal-title":"Blood"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.seminhematol.2011.05.002","volume":"48","author":"C Pott","year":"2011","unstructured":"Pott C (2011) Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevance. Semin Hematol 48:172\u2013184","journal-title":"Semin Hematol"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbmt.2011.07.002","volume":"18","author":"M Korthals","year":"2012","unstructured":"Korthals M, Sehnke N, Kronenwett R et al (2012) The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameter. Biol Blood Marrow Transplant 18:423\u2013431","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2013-06-507319","volume":"122","author":"M Ladetto","year":"2013","unstructured":"Ladetto M, Lobetti-Bodoni C, Mantoan B et al (2013) Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program. Blood 122:3759\u20133766","journal-title":"Blood"},{"issue":"3","key":"14_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/leu.2014.219","volume":"29","author":"S Ferrero","year":"2015","unstructured":"Ferrero S, Ladetto M, Drandi D et al (2015) Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics\u2019 impact on survival. Leukemia 29(3):689\u2013695","journal-title":"Leukemia"},{"issue":"5","key":"14_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/leu.2015.269","volume":"30","author":"M Ladetto","year":"2015","unstructured":"Ladetto M, Ferrero S, Drandi D et al (2016) Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. Leukemia 30(5):1211\u20131214","journal-title":"Leukemia"},{"issue":"12","key":"14_CR9","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","volume":"78","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman A, Woo SD et al (1991) All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78(12):3275\u20133280","journal-title":"Blood"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"issue":"7","key":"14_CR11","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","volume":"83","author":"R Rimokh","year":"1994","unstructured":"Rimokh R, Berger F, Delsol G et al (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83(7):1871\u20131875","journal-title":"Blood"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1083-8791(00)70006-1","volume":"6","author":"M Ladetto","year":"2000","unstructured":"Ladetto M, Donovan JW, Harig S et al (2000) Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma. Biol Blood Marrow Transplant 6:241\u2013253","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.leu.2401831","volume":"14","author":"M Br\u00fcggemann","year":"2000","unstructured":"Br\u00fcggemann M, Droese J, Bolz I et al (2000) Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 14:1419\u20131425","journal-title":"Leukemia"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VH Velden van der","year":"2007","unstructured":"van der Velden VH, Cazzaniga G, Schrauder A et al (2007) Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604\u2013611","journal-title":"Leukemia"},{"issue":"6","key":"14_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","volume":"17","author":"VH Velden van der","year":"2003","unstructured":"van der Velden VH, Hochhaus A, Cazzaniga G et al (2003) Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 17(6):1013\u20131034","journal-title":"Leukemia"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-62703-269-8_10","volume":"971","author":"C Pott","year":"2013","unstructured":"Pott C, Br\u00fcggemann M, Ritgen M et al (2013) MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR. Methods Mol Biol 971:175\u2013200","journal-title":"Methods Mol Biol"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/leu.2013.375","volume":"28","author":"M Ladetto","year":"2014","unstructured":"Ladetto M, Br\u00fcggemann M, Monitillo L et al (2014) Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia 28:1299\u20131307","journal-title":"Leukemia"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1182\/blood-2014-01-550020","volume":"123","author":"J Martinez-Lopez","year":"2014","unstructured":"Martinez-Lopez J, Lahuerta JJ, Pepin F et al (2014) Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma. Blood 123:3073\u20133079","journal-title":"Blood"},{"issue":"26","key":"14_CR19","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1182\/blood-2015-03-580027","volume":"125","author":"JJ Dongen van","year":"2015","unstructured":"van Dongen JJ, van der Velden VH, Br\u00fcggemann M et al (2015) Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. Blood 125(26):3996\u20134009","journal-title":"Blood"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2011.36.9348","volume":"30","author":"S B\u00f6ttcher","year":"2012","unstructured":"B\u00f6ttcher S, Ritgen M, Fischer K et al (2012) Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial. J Clin Oncol 30:980\u2013988","journal-title":"J Clin Oncol"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1200\/JCO.2012.46.2119","volume":"31","author":"AC Rawstron","year":"2013","unstructured":"Rawstron AC, Child JA, de Tute RM et al (2013) Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study. J Clin Oncol 31:2540\u20132547","journal-title":"J Clin Oncol"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1182\/blood-2011-07-370460","volume":"119","author":"B Paiva","year":"2012","unstructured":"Paiva B, Guti\u00e9rrez NC, Rosi\u00f1ol L et al (2012) High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma. Blood 119:687\u2013691","journal-title":"Blood"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ymeth.2010.01.030","volume":"50","author":"AL Markey","year":"2010","unstructured":"Markey AL, Mohr S, Day PJ (2010) High-throughput droplet PCR. Methods 50:277\u2013281","journal-title":"Methods"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA et al (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604\u20138610","journal-title":"Anal Chem"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1021\/ac202578x","volume":"84","author":"LB Pinheiro","year":"2012","unstructured":"Pinheiro LB, Coleman VA, Hindson CM et al (2012) Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem 84:1003\u20131011","journal-title":"Anal Chem"},{"issue":"1","key":"14_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ymeth.2012.08.001","volume":"59","author":"E Day","year":"2013","unstructured":"Day E, Dear PH, McCaughan F (2013) Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine. Methods 59(1):101\u2013107","journal-title":"Methods"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1373\/clinchem.2012.193409","volume":"59","author":"A Didelot","year":"2013","unstructured":"Didelot A, Kotsopoulos SK, Lupo A et al (2013) Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples. Clin Chem 59:815\u2013823","journal-title":"Clin Chem"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1373\/clinchem.2013.211045","volume":"59","author":"TC Dingle","year":"2013","unstructured":"Dingle TC, Sedlak RH, Cook L et al (2013) Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances. Clin Chem 59:1670\u20131672","journal-title":"Clin Chem"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1128\/JCM.02620-12","volume":"51","author":"RT Hayden","year":"2013","unstructured":"Hayden RT, Gu Z, Ingersoll J, Abdul-Ali D (2013) Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus. J Clin Microbiol 51:540\u2013546","journal-title":"J Clin Microbiol"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","volume":"10","author":"CM Hindson","year":"2013","unstructured":"Hindson CM, Chevillet JR, Briggs HA et al (2013) Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 10:1003\u20131005","journal-title":"Nat Methods"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1373\/clinchem.2013.214742","volume":"59","author":"JF Huggett","year":"2013","unstructured":"Huggett JF, Whale A (2013) Digital PCR as a novel technology and its potential implications for molecular diagnostics. Clin Chem 59:1691\u20131693","journal-title":"Clin Chem"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1021\/ac500208w","volume":"86","author":"G Nixon","year":"2014","unstructured":"Nixon G, Garson JA, Grant P et al (2014) Comparative study of sensitivity, linearity, and resistance to inhibition of digital and nondigital polymerase chain reaction and loop mediated isothermal amplification assays for quantification of human cytomegalovirus. Anal Chem 86:4387\u20134394","journal-title":"Anal Chem"},{"issue":"1","key":"14_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1373\/clinchem.2014.221366","volume":"61","author":"JF Huggett","year":"2015","unstructured":"Huggett JF, Cowen S, Foy CA (2015) Considerations for digital PCR as an accurate molecular diagnostic tool. Clin Chem 61(1):79\u201388","journal-title":"Clin Chem"},{"issue":"6","key":"14_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jmoldx.2015.05.007","volume":"17","author":"D Drandi","year":"2015","unstructured":"Drandi D, Kubiczkova-Besse L, Ferrero S et al (2015) Minimal residual disease detection by droplet digital PCR in multiple myeloma, mantle cell lymphoma, and follicular lymphoma. A comparison with real-time PCR. J Mol Diagn 17(6):652\u2013660","journal-title":"J Mol Diagn"},{"key":"14_CR35","first-page":"726","volume":"5","author":"M Deane","year":"1991","unstructured":"Deane M, McCarthy KP, Wiedemann LM et al (1991) An improved method for detection of B-lymphoid clonality by polimerase chain reaction. Leukemia 5:726","journal-title":"Leukemia"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/sj.leu.2400801","volume":"11","author":"C Voena","year":"1997","unstructured":"Voena C, Ladetto M, Astolfi M et al (1997) A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia 11:1793","journal-title":"Leukemia"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1200\/JCO.2001.19.2.420","volume":"19","author":"KE Summers","year":"2001","unstructured":"Summers KE, Goff LK, Wilson AG et al (2001) Frequency of the Bcl-2\/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 19:420\u2013424","journal-title":"J Clin Oncol"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","volume":"160","author":"A Albinger-Hegyi","year":"2002","unstructured":"Albinger-Hegyi A, Hochreutener B, Abdou MT et al (2002) High frequency of t(14;18) translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas improved polymerase chain reaction protocols for their detection. Am J Pathol 160:823\u2013832","journal-title":"Am J Pathol"},{"issue":"8","key":"14_CR39","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"M Ladetto","year":"2008","unstructured":"Ladetto M, De Marco F, Benedetti F et al (2008) Prospective, multicenter randomized GITMO\/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. Blood 111(8):4004\u20134013","journal-title":"Blood"},{"issue":"2","key":"14_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0301-472X(00)00651-2","volume":"29","author":"M Ladetto","year":"2001","unstructured":"Ladetto M, Sametti S, Donovan JW et al (2001) A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. Exp Hematol 29(2):183\u2013193","journal-title":"Exp Hematol"},{"issue":"3","key":"14_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hon.2095","volume":"32","author":"I Della Starza","year":"2014","unstructured":"Della Starza I, Cavalli M, Del Giudice I et al (2014) Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance. Hematol Oncol 32(3):133\u2013138","journal-title":"Hematol Oncol"}],"container-title":["Methods in Molecular Biology","Digital PCR"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7778-9_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T04:15:44Z","timestamp":1571285744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7778-9_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493977765","9781493977789"],"references-count":41,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7778-9_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}